1/40
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
HIT characteristics
Prothrombotic disorder
50% platelet drop or less than 100,000 platelet count
5-14 days after starting heparin
What is HIT related to?
30-50% related arterial &/or venous thromboembolism.
HIT MOA
Pt’s who form antibodies against Heparin & PF4 complex causing platelet activation leading to clumping & eventual clot
Which type of Heparin is worse?
Bovine lung worse than porcine
HIT epidemiology
More prevalent in females than males
Mortality rate up to 30%
20% untreated undergo single or multiple amputations
Methods to detect HIT
Immunoassay - detects binding of anti-PF4 heparin antibodies
Functional Assay - platelet activation tests
Types of functional assays
Activate platelets in the presence of heparin
Serotonin Release Assay (SRA)
Heparin induced platelet activation (HIPA)
Acute HIT characteristics
Persists until platelets recover
Functional & immunoassay Positive
↓ platelet count
Subacute A HIT characteristics
Period of platelet recovery
Functional assay still positive
Subacute A HIT Treatment plan
Delay surgery
Use Heparin alternative
Pre-op plasma exchange
Subacute B HIT characteristics
Platelets recovered
Immunoassay still Positive
Subacute B HIT Treatment plan
Use Heparin (Porcine preferred)
Remote HIT
Anti-PF4/heparin antibodies no longer detectable
Treatment plan: Use Heparin
Heparin alternatives
Bivalrudin (Angiomax)
Most common
Argatroban (Acova)
Use for renal dysfunction pt’s
DTI’s
Bivalrudin Suggested protocol
25 min ½ life
Bolus 50 mg in prime
Pt loading dose 1 mg/kg by anesthesia
Continuous infusion 2.5 mg/kg/hr by anesthesia
ATS for HIT
All shed blood to cell saver (no pump sucker usage)
Use anticoagulant CPD (Citrate Phosphate Dextrose)
Prolonged R-value
Hypocoagulable state
Possible d/t heparin presence or ↓ coagulation factors
Treat w/ FFP or protamine
DEC’d R-value
Hypercoagulable state
K-value meaning
Fibrin contribution to clot strength
Speed of clot formation
Prolonged K-value
Fibrinogen deficiency
Treat w/ Cryoprecipitate
R-value meaning
Time of formation of fibrin strand polymer
Time it takes for clotting to begin (similar to ACT)
MA meaning
Clot strength / platelet function
DEC’d MA value
Lower platelet levels
Treat w/ platelets or DDAVP
LY 30 meaning
Clot breakdown / fibrinolysis 30 min after MA
DEC’d LY 30 value
Rapid consumption
Treat w/ TXA
Brandy Snifter
Normal / Do nothing
Wine glass
Factor deficiency
Give FFP
Champagne flute
Fibrinogen deficiency
Give Cryo/fibrinogen
Test tube
Thrombocytopenia
Give platelets
Inverted Martini glass
Fibrinolysis
Give TXA
Heparin Assay Device Medtronic HMS Plus
Calculates estimated heparin dosage
Measures circulating level of Heparin
Calculates protamine dosage based on circulating heparin level
Detects residual heparin post protamine
#1 cause of clotted circuits
Protamine
Insufficient ACT
Give more Heparin
AT III for heparin resistance
Use of FFP
Heparin Resistance causes
Previous use of Heparin
Pregnancy
Shock
AT III deficiency
Infective endocarditis
Less frequent Clotted circuit causes
Recalcification of blood prime before adding heparin
Platelet fibrination of oxy
False clotted circuit conditions
HPE
Cold agglutinins
Cold agglutinins
Circulating autoantibodies
Activate at a certain hypothermia level
HPE
W/in several min of CPB onset, pre oxy pressure INC’s
Flow drops w/ no RPM change
HPE causes
Lipid, Protein, Platelet aggregation in oxy fibers
Associated w/ Diprivan usage (Lipid based drug)
Not using Albumin in pump prime
HPE treatment
Warm pt
Give at least 10 mL of 25% Albumin
Clotted circuit Remediation
Safely & rapidly change out the circuit (assume clot is elsewhere)